Literature DB >> 17509856

A simple rapid immunoassay for S-adenosylhomocysteine in plasma.

Antonieta Capdevila1, Raymond F Burk, Joshua Freedman, Frank Frantzen, Ingrid Alfheim, Conrad Wagner.   

Abstract

The measurement of plasma S-adenosylhomocysteine is a more sensitive indicator of the risk for vascular disease than is plasma homocysteine. Because the level of S-adenosylhomocysteine is normally in the nanomolar range, it has been difficult to measure and necessitated the development of complex fluorometric and mass-spectrophotometric methods. We have now adapted an existing immunoassay used for the measurement of homocysteine to the measurement of S-adenosylhomocysteine in plasma. This assay is sensitive down to the level of less than 0.1 pmol, and there is no interference by S-adenosylmethionine. The assay is carried out in microplates, allows the measurement of 12 samples per plate and can easily be carried out in a 4-h period. The method is applicable to plasma samples having S-adenosylhomocysteine concentrations ranging from 10 to 150 nM without dilution. The mean value for 16 normal subjects by this method was 18.9+/-1.4 nM (S.E.M.), compared with 17.8+/-1.4 nM obtained by a previously described method using two high-performance liquid chromatography columns with fluorescence derivatization. Mean values for seven cirrhotic patients were 46.5+/-3.3 nM by this new method compared with 44.6+/-5.3 by the former method. The ease and speed of this method should allow the widespread measurement of this important metabolite in laboratories without access to sophisticated equipment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17509856      PMCID: PMC2196216          DOI: 10.1016/j.jnutbio.2007.01.003

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  22 in total

1.  Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine.

Authors:  D M Kerins; M J Koury; A Capdevila; S Rana; C Wagner
Journal:  Am J Clin Nutr       Date:  2001-12       Impact factor: 7.045

2.  Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations.

Authors:  S Melnyk; M Pogribna; I P Pogribny; P Yi; S J James
Journal:  Clin Chem       Date:  2000-02       Impact factor: 8.327

3.  Quantification of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent 1,N(6)-etheno derivatives: an adaptation of previously described methodology.

Authors:  Rita Castro; Eduard A Struys; Erwin E W Jansen; Henk J Blom; Isabel Tavares de Almeida; Cornelis Jakobs
Journal:  J Pharm Biomed Anal       Date:  2002-07-31       Impact factor: 3.935

4.  Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Authors:  Sudha Seshadri; Alexa Beiser; Jacob Selhub; Paul F Jacques; Irwin H Rosenberg; Ralph B D'Agostino; Peter W F Wilson; Philip A Wolf
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

5.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

6.  Relationship between plasma S-adenosylhomocysteine concentration and glomerular filtration rate in children.

Authors:  Kathy Jabs; Mark J Koury; William D Dupont; Conrad Wagner
Journal:  Metabolism       Date:  2006-02       Impact factor: 8.694

Review 7.  The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.

Authors: 
Journal:  Cerebrovasc Dis       Date:  2002       Impact factor: 2.762

8.  Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable-isotope dilution tandem mass spectrometry.

Authors:  E A Struys; E E Jansen; K de Meer; C Jakobs
Journal:  Clin Chem       Date:  2000-10       Impact factor: 8.327

9.  Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology.

Authors:  S Jill James; Stepan Melnyk; Marta Pogribna; Igor P Pogribny; Marie A Caudill
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

10.  Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland.

Authors:  Stephen P McIlroy; Kevin B Dynan; John T Lawson; Christopher C Patterson; A Peter Passmore
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

View more
  5 in total

1.  Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors.

Authors:  Rui Wang; Glorymar Ibáñez; Kabirul Islam; Weihong Zheng; Gil Blum; Caitlin Sengelaub; Minkui Luo
Journal:  Mol Biosyst       Date:  2011-08-24

2.  A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.

Authors:  Amy M Quinn; Abdellah Allali-Hassani; Masoud Vedadi; Anton Simeonov
Journal:  Mol Biosyst       Date:  2010-03-02

3.  Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men.

Authors:  William Shin; Jian Yan; Christian M Abratte; Francoise Vermeylen; Marie A Caudill
Journal:  J Nutr       Date:  2010-03-10       Impact factor: 4.798

Review 4.  Current chemical biology approaches to interrogate protein methyltransferases.

Authors:  Minkui Luo
Journal:  ACS Chem Biol       Date:  2012-02-01       Impact factor: 5.100

5.  A universal competitive fluorescence polarization activity assay for S-adenosylmethionine utilizing methyltransferases.

Authors:  Tiffany L Graves; Yi Zhang; John E Scott
Journal:  Anal Biochem       Date:  2007-09-29       Impact factor: 3.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.